Eosinophilic Esophagitis Drug Market Will Surge at 5.5% CAGR to Reach 160 Million US$ by the End of 2025: AstraZeneca, GSK, Bayer
Eosinophilic esophagitis (EoE, also spelled eosinophilic oesophagitis), also known as allergic oesophagitis, is an allergic inflammatory condition of the esophagus that involves eosinophils, a type of white blood cell. Symptoms are swallowing difficulty, food impaction, vomiting, and heartburn.
View full press release